Mitotane comes in several versions
Mitotane/Mitotane is a drug used to treat adrenocortical cancer. Its main function is to reduce the growth of tumor cells by inhibiting the function of the adrenal cortex. Mitotane was originally developed and marketed by Bristol Myers Squibb and has become one of the important options for the treatment of adrenocortical cancer. The drug effectively reduces adrenal hormone levels in the body by selectively destroying adrenocortical cells, which plays an important role in controlling the progression of the disease.
Over time, mitotane's patent expired, allowing other pharmaceutical companies to enter the market and begin producing and selling generic versions of it. Today, there are many pharmaceutical companies around the world involved in the production of mitotane, including some well-known large pharmaceutical companies and biopharmaceutical companies. These companies not only focus on the efficacy of drugs, but also strive to improve production processes and reduce production costs to better meet the needs of different markets.
At present, the generic version of mitotane mainly comes from some pharmaceutical companies in Laos, such as Lao Daxiong Pharmaceutical, Lao Lucius Pharmaceutical and Lao ASEAN Pharmaceutical. The mitotane produced by these companies is basically the same as the original version in terms of drug ingredients, therapeutic effects and specifications, ensuring that patients will obtain similar therapeutic effects when using it. However, the price of these generic drugs is usually lower than the brand-name drugs, which makes treatment affordable for more patients, thus increasing its accessibility.
In addition to the Lao pharmaceutical companies mentioned above, other countries and regions are also developing and producing generic versions of mitotane. These efforts not only enrich the market options of mitotane, but also provide patients with more flexible medication options. At the same time, with the continuous advancement of clinical research, the indications and usage of mitotane are also constantly improved, and doctors can develop personalized treatment plans based on the specific conditions of patients.
Reference materials:https://www.drugs.com/dosage/mitotane.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)